drugset / Trial / NCT02223000
Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Comparative pharmacokinetics of 2-4 experimental modified release formulations and oral solution of BIBV 308 SE following multiple doses, tolerability
Timeline
- Start
- 1998-03
- Primary completion
- 1998-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terbogrel | Small molecule | 50 mg | Oral |
Indications
No indication recorded.